Drug Shortage Report for TEVA-VALSARTAN/HCTZ

Last updated on 2018-05-11 History
Report ID 1226
Drug Identification Number 02357046
Brand name TEVA-VALSARTAN/HCTZ
Common or Proper name TEVA-VALSARTAN/HCTZ
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 25MG 320MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-02-01
Estimated end date 2018-04-30
Actual end date 2018-04-30
Shortage status Resolved
Updated date 2018-05-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2018-05-11 French Compare
v17 2018-05-11 English Compare
v16 2018-03-13 French Compare
v15 2018-03-13 English Compare
v14 2017-12-15 French Compare
v13 2017-12-15 English Compare
v12 2017-10-10 French Compare
v11 2017-10-10 English Compare
v10 2017-05-23 French Compare
v9 2017-05-23 English Compare
v8 2017-05-08 French Compare
v7 2017-05-08 English Compare
v6 2017-04-25 French Compare
v5 2017-04-25 English Compare
v4 2017-04-03 French Compare
v3 2017-04-03 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare